ClinicalTrials.govpublic full text
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
acute myeloid leukemia, myelodysplastic syndromes, bgb324, bemcentinib, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 894907
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.